Neuraxpharm Pharmaceuticals S.L.
SpainAll drugs from this manufacturer
-
It is used to treat adults with relapsing forms of multiple sclerosis (RMS), a disease that affects the central nervous system and is characterized by flare-ups of symptoms followed by periods of improvement.
Dosage form: solution for infusion, concentrate
Active substance Dosage ublituximab 150 mg -
It is used to stop a sudden, prolonged seizure in infants (from 3 months old) and adults.
Dosage form: solution, oral
Active substance Dosage midazolam hydrochloride 5,00 mg -
It is used to stop a sudden and prolonged seizure in infants (from 3 months of age) and adults who have been diagnosed with epilepsy.
Dosage form: solution, oral
Active substance Dosage midazolam hydrochloride 5,00 mg -
It is used to stop a sudden and prolonged seizure in infants (from 3 months old) and adults diagnosed with epilepsy.
Dosage form: solution, oral
Active substance Dosage midazolam hydrochloride 5,00 mg -
It is used to stop a sudden and prolonged seizure in infants (from 3 months old) and adults.
Dosage form: solution, oral
Active substance Dosage midazolam hydrochloride 5,00 mg -
It is used in adults with narcolepsy to help them stay awake and reduce the likelihood of experiencing sudden sleep attacks.
Dosage form: tablets
Active substance Dosage modafinil 100 mg -
It is used as maintenance treatment for the symptoms of schizophrenia in adults who were already stabilized with paliperidone or risperidone.
Dosage form: suspension for injection, prolonged release
Active substance Dosage paliperidone palmitate 156 mg -
It is used as maintenance treatment for the symptoms of schizophrenia in adults who have already been stabilized with paliperidone or risperidone.
Dosage form: suspension for injection, prolonged release
Active substance Dosage paliperidone palmitate 234 mg -
It is used as maintenance treatment for the symptoms of schizophrenia in adults who have been previously stabilized with paliperidone or risperidone.
Dosage form: suspension for injection, prolonged release
Active substance Dosage paliperidone palmitate 39 mg -
It is used as maintenance treatment for symptoms of schizophrenia in adult patients who were previously stabilized on paliperidone or risperidone.
Dosage form: suspension for injection, prolonged release
Active substance Dosage paliperidone palmitate 78 mg -
It is used as maintenance treatment for the symptoms of schizophrenia in adults who have already been stabilized with paliperidone or risperidone.
Dosage form: suspension for injection, prolonged release
Active substance Dosage paliperidone palmitate 117 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control symptoms. It can help improve attention and concentration, and reduce impulsivity and hyperactivity.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 1,148 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other medications are not suitable or do not adequately control the symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 2,296 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other medications are not suitable or do not adequately control the symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 3,444 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control the symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 4,592 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 5,740 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control the symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 6,88 mg -
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control symptoms.
Dosage form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 8,036 mg